SG

Sandipkumar Gopalbhai Patel

Active Director Director DIN 07543770
DIN 07543770 First appointment Jul 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Jul 2016
Shareholding value •••• Premium profile

About Sandipkumar Gopalbhai Patel

Data last updated:

Sandipkumar Gopalbhai Patel is a Director at Soxa Formulations And Research Private Limited (since 2016), Director at Nephrine Pharmaceuticals Private Limited (since 2026) and Partner at Gramino Healthcare Llp (since 2024). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Soxa Formulations And Research Private Limited at ₹11.33 Cr (FY 2025).

DIN 07543770
Primary Designation Director
Industry Healthcare
First Appointment 25 Jul 2016
Oldest Company Age 11 yrs
Largest company Soxa Formulations And Research Private Limited · ₹11.33 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20162015₹11.33 Cr (FY 2025)Active
Director23 Feb 20262026Active
Partner07 Jun 20242024Active

Directorship timeline

Open interactive timeline →
Soxa Formulations And Research Private Limited
Gramino Healthcare Llp
Nephrine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sandipkumar Gopalbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandipkumar Gopalbhai Patel

Sandipkumar Gopalbhai Patel currently holds 3 directorships: Soxa Formulations And Research Private Limited (Director, since 25 Jul 2016, revenue ₹11.33 Cr (FY 2025)); Nephrine Pharmaceuticals Private Limited (Director, since 23 Feb 2026); Gramino Healthcare Llp (Partner, since 07 Jun 2024).

Sandipkumar Gopalbhai Patel was first appointed on 25 Jul 2016 as Director at Soxa Formulations And Research Private Limited. The most recent appointment on record is 23 Feb 2026 at Nephrine Pharmaceuticals Private Limited.

The current boards of Sandipkumar Gopalbhai Patel's companies include Bharatkumar Haribhai Patel (Soxa Formulations And Research Private Limited), Brijeshkumar Keshabhai Patel (Soxa Formulations And Research Private Limited), Vimalkumar Manibhai Patel (Soxa Formulations And Research Private Limited), Piyushkumar Kantibhai Patel (Nephrine Pharmaceuticals Private Limited), Chintan Bharatbhai Patel (Gramino Healthcare Llp), Chiragkumar Sureshbhai Patel (Gramino Healthcare Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available